Powered by
ROYAL OAK—Immunis.AI Inc., a biotech company developing noninvasive blood-based tests for disease, announced the publication of pivotal results from its clinical trial, Evaluation of an RNAseq-based Immunogenomic Liquid Biopsy Approach …
ANN ARBOR—Celsee Inc., the single-cell isolation and analysis developer, announced an agreement to provide scientists at China’s Kindstar Global, a medical testing service,with Celsee’s Genesis System for monitoring circulating tumor …
ROYAL OAK—OncoCell MDx Inc., a startup incubated at Harvard University to develop sophisticated cancer diagnosis from a simple blood sample, announced that it has raised $22.2 million in a Preferred …